Astute Medical Completes $40.4 Million Series C Financing
News Jun 11, 2012
Astute Medical, Inc. has announced the completion of a $40.4 million Series C financing led by MPM Capital and including new investor Kaiser Permanente Ventures.
The Company intends to use the proceeds to begin commercializing its first product, as well as to advance and expand its research, development and validation of biomarker-based laboratory tests.
“Astute Medical has made rapid progress in its development of biomarker-based diagnostics to address major unmet medical needs,” commented Jim Scopa, managing director of MPM Capital.
Scopa continued, “We are excited to fund the commercialization of Astute’s first product as well as the continued development of the pipeline.”
“We believe the successful completion of this financing reflects upon the tremendous progress made thus far in our research, development and clinical activities,” said Christopher Hibberd, Astute Medical chief executive officer.
Hibberd continued, “We are pleased to have the confidence of an outstanding group of life science-oriented investors and believe we are well positioned to build a strong, sustainable pipeline of high-utility diagnostic products.”
Additional participants in the financing included existing stockholders De Novo Ventures, Delphi Ventures, Domain Associates and Johnson & Johnson Development Corporation.
New Rapid Test for Valley Fever Should Help Reduce Diagnosis DelaysNews
November saw a spike if cases of Valley fever. Fortunately, the recent—and timely—approval of a new rapid assay test for Valley fever should reduce delays in diagnosing the respiratory fungal infections—a frequent problem in treating the disease, which is caused by spores endemic to soils in the U.S. Southwest.READ MORE
Blood Sample Detection Method for Multiple Sclerosis DiscoveredNews
A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team. The process will avoid the invasive, painful process of collecting fluid from the brain and spineREAD MORE
Faster, More Accurate Cancer Detection Using NanoparticlesNews
Using light-emitting nanoparticles, Rutgers University-New Brunswick scientists have invented a highly effective method to detect tiny tumors and track their spread, potentially leading to earlier cancer detection and more precise treatment.READ MORE